Correction to: Generation of T-cell-receptor-negative CD8αβ-positive CAR T cells from T-cell-derived induced pluripotent stem cells (Nature Biomedical Engineering, (2022), 6, 11, (1284-1297), 10.1038/s41551-022-00915-0)

Sjoukje J. C. van der Stegen; Pieter L. Lindenbergh; Roseanna M. Petrovic; Hongyao Xie; Mame P. Diop; Vera Alexeeva; Yuzhe Shi; Jorge Mansilla-Soto; Mohamad Hamieh; Justin Eyquem; Annalisa Cabriolu; Xiuyan Wang; Ramzey Abujarour; Tom Lee; Raedun Clarke; Bahram Valamehr; Maria Themeli; Isabelle Riviere; Michel Sadelain

doi:10.1038/s41551-024-01181-y

Correction to: Generation of T-cell-receptor-negative CD8αβ-positive CAR T cells from T-cell-derived induced pluripotent stem cells (Nature Biomedical Engineering, (2022), 6, 11, (1284-1297), 10.1038/s41551-022-00915-0)

Sjoukje J. C. van der Stegen, Pieter L. Lindenbergh, Roseanna M. Petrovic, Hongyao Xie, Mame P. Diop, Vera Alexeeva, Yuzhe Shi, Jorge Mansilla-Soto, Mohamad Hamieh, Justin Eyquem, Annalisa Cabriolu, Xiuyan Wang, Ramzey Abujarour, Tom Lee, Raedun Clarke, Bahram Valamehr, Maria Themeli, Isabelle Riviere, Michel Sadelain

Research output: Contribution to journal › Comment/Letter to the editor › Academic

Abstract

Correction to: Nature Biomedical Engineeringhttps://doi.org/10.1038/s41551-022-00915-0, published online 8 August 2022. In the version of this article originally published, the Competing interests section did not include the text “Memorial Sloan Kettering has licensed intellectual property on which M.S. is a named inventor to Fate Therapeutics. M.S. does not receive consultation fees or forms of remuneration”. The statement has been inserted in the HTML and PDF versions of the article.

Original language	English
Journal	Nature Biomedical Engineering
Early online date	2024
DOIs	https://doi.org/10.1038/s41551-024-01181-y
Publication status	E-pub ahead of print - 2024

Access to Document

10.1038/s41551-024-01181-y

Cite this

van der Stegen, S. J. C., Lindenbergh, P. L., Petrovic, R. M., Xie, H., Diop, M. P., Alexeeva, V., Shi, Y., Mansilla-Soto, J., Hamieh, M., Eyquem, J., Cabriolu, A., Wang, X., Abujarour, R., Lee, T., Clarke, R., Valamehr, B., Themeli, M., Riviere, I., & Sadelain, M. (2024). Correction to: Generation of T-cell-receptor-negative CD8αβ-positive CAR T cells from T-cell-derived induced pluripotent stem cells (Nature Biomedical Engineering, (2022), 6, 11, (1284-1297), 10.1038/s41551-022-00915-0). Nature Biomedical Engineering. Advance online publication. https://doi.org/10.1038/s41551-024-01181-y

@article{1bf0a2e427664efe9bd1c73abb938576,

title = "Correction to: Generation of T-cell-receptor-negative CD8αβ-positive CAR T cells from T-cell-derived induced pluripotent stem cells (Nature Biomedical Engineering, (2022), 6, 11, (1284-1297), 10.1038/s41551-022-00915-0)",

abstract = "Correction to: Nature Biomedical Engineeringhttps://doi.org/10.1038/s41551-022-00915-0, published online 8 August 2022. In the version of this article originally published, the Competing interests section did not include the text “Memorial Sloan Kettering has licensed intellectual property on which M.S. is a named inventor to Fate Therapeutics. M.S. does not receive consultation fees or forms of remuneration”. The statement has been inserted in the HTML and PDF versions of the article.",

author = "{van der Stegen}, {Sjoukje J. C.} and Lindenbergh, {Pieter L.} and Petrovic, {Roseanna M.} and Hongyao Xie and Diop, {Mame P.} and Vera Alexeeva and Yuzhe Shi and Jorge Mansilla-Soto and Mohamad Hamieh and Justin Eyquem and Annalisa Cabriolu and Xiuyan Wang and Ramzey Abujarour and Tom Lee and Raedun Clarke and Bahram Valamehr and Maria Themeli and Isabelle Riviere and Michel Sadelain",

note = "Publisher Copyright: {\textcopyright} The Author(s), under exclusive licence to Springer Nature Limited 2024.",

year = "2024",

doi = "10.1038/s41551-024-01181-y",

language = "English",

journal = "Nature Biomedical Engineering",

issn = "2157-846X",

publisher = "Nature Publishing Group",

}

van der Stegen, SJC, Lindenbergh, PL, Petrovic, RM, Xie, H, Diop, MP, Alexeeva, V, Shi, Y, Mansilla-Soto, J, Hamieh, M, Eyquem, J, Cabriolu, A, Wang, X, Abujarour, R, Lee, T, Clarke, R, Valamehr, B, Themeli, M, Riviere, I & Sadelain, M 2024, 'Correction to: Generation of T-cell-receptor-negative CD8αβ-positive CAR T cells from T-cell-derived induced pluripotent stem cells (Nature Biomedical Engineering, (2022), 6, 11, (1284-1297), 10.1038/s41551-022-00915-0)', Nature Biomedical Engineering. https://doi.org/10.1038/s41551-024-01181-y

Correction to: Generation of T-cell-receptor-negative CD8αβ-positive CAR T cells from T-cell-derived induced pluripotent stem cells (Nature Biomedical Engineering, (2022), 6, 11, (1284-1297), 10.1038/s41551-022-00915-0). / van der Stegen, Sjoukje J. C.; Lindenbergh, Pieter L.; Petrovic, Roseanna M. et al.
In: Nature Biomedical Engineering, 2024.

Research output: Contribution to journal › Comment/Letter to the editor › Academic

TY - JOUR

T1 - Correction to

T2 - Generation of T-cell-receptor-negative CD8αβ-positive CAR T cells from T-cell-derived induced pluripotent stem cells (Nature Biomedical Engineering, (2022), 6, 11, (1284-1297), 10.1038/s41551-022-00915-0)

AU - van der Stegen, Sjoukje J. C.

AU - Lindenbergh, Pieter L.

AU - Petrovic, Roseanna M.

AU - Xie, Hongyao

AU - Diop, Mame P.

AU - Alexeeva, Vera

AU - Shi, Yuzhe

AU - Mansilla-Soto, Jorge

AU - Hamieh, Mohamad

AU - Eyquem, Justin

AU - Cabriolu, Annalisa

AU - Wang, Xiuyan

AU - Abujarour, Ramzey

AU - Lee, Tom

AU - Clarke, Raedun

AU - Valamehr, Bahram

AU - Themeli, Maria

AU - Riviere, Isabelle

AU - Sadelain, Michel

PY - 2024

Y1 - 2024

N2 - Correction to: Nature Biomedical Engineeringhttps://doi.org/10.1038/s41551-022-00915-0, published online 8 August 2022. In the version of this article originally published, the Competing interests section did not include the text “Memorial Sloan Kettering has licensed intellectual property on which M.S. is a named inventor to Fate Therapeutics. M.S. does not receive consultation fees or forms of remuneration”. The statement has been inserted in the HTML and PDF versions of the article.

AB - Correction to: Nature Biomedical Engineeringhttps://doi.org/10.1038/s41551-022-00915-0, published online 8 August 2022. In the version of this article originally published, the Competing interests section did not include the text “Memorial Sloan Kettering has licensed intellectual property on which M.S. is a named inventor to Fate Therapeutics. M.S. does not receive consultation fees or forms of remuneration”. The statement has been inserted in the HTML and PDF versions of the article.

UR - http://www.scopus.com/inward/record.url?scp=85184911093&partnerID=8YFLogxK

U2 - 10.1038/s41551-024-01181-y

DO - 10.1038/s41551-024-01181-y

M3 - Comment/Letter to the editor

C2 - 38347164

SN - 2157-846X

JO - Nature Biomedical Engineering

JF - Nature Biomedical Engineering

ER -

van der Stegen SJC, Lindenbergh PL, Petrovic RM, Xie H, Diop MP, Alexeeva V et al. Correction to: Generation of T-cell-receptor-negative CD8αβ-positive CAR T cells from T-cell-derived induced pluripotent stem cells (Nature Biomedical Engineering, (2022), 6, 11, (1284-1297), 10.1038/s41551-022-00915-0). Nature Biomedical Engineering. 2024. Epub 2024. doi: 10.1038/s41551-024-01181-y

Correction to: Generation of T-cell-receptor-negative CD8αβ-positive CAR T cells from T-cell-derived induced pluripotent stem cells (Nature Biomedical Engineering, (2022), 6, 11, (1284-1297), 10.1038/s41551-022-00915-0)

Abstract

Access to Document

Other files and links

Cite this